2-Methoxy-5-(trifluoromethyl)benzoic acid, 97.0%, 5g

(R)-1-(2-Chlorophenyl)ethanamine hydrochloride, 95.0%, 1g

tBuXPhos Pd G1, 250mg

tert-Butyl 2-bromo-3-phenylpropanoate, 97%, 10g

(2R,4aR,6S,7R,8R,8aS)-6-Methoxy-2-(4-methoxyphenyl)hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol, 98%, 50mg

N-(sec-butyl)cyclopentanamine hydrobromide, 95.0%, 1g

(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, 97%, 1g

4-NITRO-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE, 95.0%, 2g

3-Phenyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-amine, 1g

(3-Oxopiperazin-2-yl)acetic acid, 97.0%, 5g

2-(2-Naphthyl)-2-propanol, 97.0%, 5g

Pyruvic acid sodium salt, min. 99%, for biochemistry, 250 g, plastic packaging.

(3-(Trifluoromethyl)pyridin-4-yl)methanol, 95%, 100mg